DR3 antibodies
    2.
    发明授权
    DR3 antibodies 失效
    DR3抗体

    公开(公告)号:US07708996B2

    公开(公告)日:2010-05-04

    申请号:US12046107

    申请日:2008-03-11

    摘要: The present invention relates to novel Death Domain Containing Receptor (DR3 and DR3-V1) proteins that are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are antibodies and fragments thereof that bind to polypeptides of the invention. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新型死亡域含有受体(DR3和DR3-V1)蛋白。 特别地,提供编码人DR3和DR3-V1蛋白的分离的核酸分子。 还提供DR3和DR3-V1多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 还提供了结合本发明多肽的抗体及其片段。 本发明还涉及用于鉴定DR3和DR3-V1活性的激动剂和拮抗剂的筛选方法。

    Death domain containing receptors
    3.
    发明授权
    Death domain containing receptors 有权
    含有受体的死亡域

    公开(公告)号:US07357927B2

    公开(公告)日:2008-04-15

    申请号:US10189189

    申请日:2002-07-05

    摘要: The present invention relates to novel Death Domain Containing Receptor (DR3 and DR3-V1) proteins that are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are antibodies and fragments thereof that bind to polypeptides of the invention. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新型死亡域含有受体(DR3和DR3-V1)蛋白。 特别地,提供编码人DR3和DR3-V1蛋白的分离的核酸分子。 还提供DR3和DR3-V1多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 还提供了结合本发明多肽的抗体及其片段。 本发明还涉及用于鉴定DR3和DR3-V1活性的激动剂和拮抗剂的筛选方法。

    Death Domain Containing Receptors
    5.
    发明申请
    Death Domain Containing Receptors 失效
    死亡域包含受体

    公开(公告)号:US20080171016A1

    公开(公告)日:2008-07-17

    申请号:US12046107

    申请日:2008-03-11

    摘要: The present invention relates to novel Death Domain Containing Receptor (DR3 and DR3-V1) proteins that are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are antibodies and fragments thereof that bind to polypeptides of the invention. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新型死亡域含有受体(DR3和DR3-V1)蛋白。 特别地,提供编码人DR3和DR3-V1蛋白的分离的核酸分子。 还提供DR3和DR3-V1多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 还提供了结合本发明多肽的抗体及其片段。 本发明还涉及用于鉴定DR3和DR3-V1活性的激动剂和拮抗剂的筛选方法。

    Death domain containing receptors
    6.
    发明授权
    Death domain containing receptors 失效
    含有受体的死亡域

    公开(公告)号:US06713061B1

    公开(公告)日:2004-03-30

    申请号:US09557908

    申请日:2000-04-21

    IPC分类号: A61K3900

    摘要: The present invention relates to novel Death Domain Containing Receptor (DR3 and DR3-V1) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新型死亡域含有受体(DR3和DR3-V1)蛋白。 特别地,提供编码人DR3和DR3-V1蛋白的分离的核酸分子。 还提供DR3和DR3-V1多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 本发明还涉及用于鉴定DR3和DR3-V1活性的激动剂和拮抗剂的筛选方法。

    Use of DR3 antibodies in the treatment of inflammatory disease
    9.
    发明授权
    Use of DR3 antibodies in the treatment of inflammatory disease 有权
    使用DR3抗体治疗炎症性疾病

    公开(公告)号:US08105589B2

    公开(公告)日:2012-01-31

    申请号:US12771910

    申请日:2010-04-30

    摘要: The present invention relates to novel Death Domain Containing Receptor (DR3 and DR3-V1) proteins that are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR3 and DR3-V1 proteins. DR3 and DR3-V1 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are antibodies and fragments thereof that bind to polypeptides of the invention. The invention further relates to screening methods for identifying agonists and antagonists of DR3 and DR3-V1 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新型死亡域含有受体(DR3和DR3-V1)蛋白。 特别地,提供编码人DR3和DR3-V1蛋白的分离的核酸分子。 还提供DR3和DR3-V1多肽,载体,宿主细胞以及用于制备它们的重组方法也是如此。 还提供了结合本发明多肽的抗体及其片段。 本发明还涉及用于鉴定DR3和DR3-V1活性的激动剂和拮抗剂的筛选方法。